Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Harvard Business School
Baxter
Dow
McKinsey

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Piribedil

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Piribedil?

Piribedil is an investigational drug.

There have been 5 clinical trials for Piribedil. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2010.

The most common disease conditions in clinical trials are Parkinson Disease, Tinnitus, and [disabled in preview]. The leading clinical trial sponsors are Desitin Arzneimittel GmbH, FGK Clinical Research GmbH, and Faculdade de Medicina de Valenca.

There are four hundred and thirty US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Piribedil
TitleSponsorPhase
Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine AgonistsFGK Clinical Research GmbHPhase 3
Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine AgonistsDesitin Arzneimittel GmbHPhase 3
PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term TherapyDesitin Arzneimittel GmbHN/A

See all Piribedil clinical trials

Clinical Trial Summary for Piribedil

Top disease conditions for Piribedil
Top clinical trial sponsors for Piribedil

See all Piribedil clinical trials

US Patents for Piribedil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Piribedil   Start Trial Therapeutic approaches for treating Parkinson's disease PHARNEXT (Issy les Moulineaux, FR)   Start Trial
Piribedil   Start Trial Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Start Trial
Piribedil   Start Trial Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE)   Start Trial
Piribedil   Start Trial Inhalable pharmaceutical compositions iCeutica Pty Ltd. (Iluka, WA, AU)   Start Trial
Piribedil   Start Trial Fast dissolving pharmaceutical composition Ferring B.V. (Hoofddorp, NL)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Piribedil

Drugname Country Document Number Estimated Expiration Related US Patent
Piribedil Australia 2012222348 2031-03-01   Start Trial
Piribedil Australia 2012222351 2031-03-01   Start Trial
Piribedil Australia 2013224959 2031-03-01   Start Trial
Piribedil Australia 2013224960 2031-03-01   Start Trial
Piribedil Australia 2014314055 2031-03-01   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.